Press release
Connected Drug Delivery Devices Market: Transforming Healthcare with Technology-Driven Innovations
Connected Drug Delivery Devices Market
The connected drug delivery devices market, valued at USD 1.18 billion in 2024, is projected to grow significantly, reaching USD 5.30 billion by 2029, with a compound annual growth rate (CAGR) of 35.13% during the forecast period (2024-2029). Enhanced connectivity with smartphones and tablets has enabled more tailored and timely medical interventions. As the healthcare industry moves toward precision medicine, the demand for devices capable of delivering personalized doses is rapidly increasing.
Report Overview - https://www.mordorintelligence.com/industry-reports/connected-drug-delivery-devices-market
Key Trends: Shaping the Future of Connected Drug Delivery Devices
1. Rising Prevalence of Chronic Diseases
Chronic conditions such as diabetes, asthma, and hypertension are increasing worldwide, driving the demand for effective and efficient drug delivery systems. Connected devices provide real-time feedback and data tracking, significantly enhancing disease management.
2. Technological Advancements in IoT and AI
The integration of Internet of Things (IoT) and Artificial Intelligence (AI) technologies into drug delivery devices allows for real-time monitoring, predictive analytics, and personalized treatment. These innovations are leading to better patient outcomes and reduced healthcare costs.
3. Increasing Focus on Patient Adherence
Medication non-adherence remains a significant challenge in healthcare. Connected drug delivery devices with features like reminders, alerts, and mobile application integration help improve adherence, ensuring patients follow their prescribed regimens.
4. Growth in Telemedicine and Remote Monitoring
The COVID-19 pandemic accelerated the adoption of telemedicine, creating a supportive ecosystem for connected devices. These solutions enable remote patient monitoring and physician-patient interaction, reducing the need for frequent hospital visits.
5. Expanding Applications Across Therapeutics
Initially designed for chronic diseases, connected drug delivery devices are now being adopted across various therapeutic areas, including oncology, autoimmune disorders, and infectious diseases, broadening their market appeal.
Market Segmentation: Insights into Key Segments
The connected drug delivery devices market is segmented by product type, technology, application, and geography, offering a comprehensive analysis of the market landscape.
By Product Type:
Connected Inhalers: Dominant due to their widespread use in asthma and COPD management.
Connected Injectors: Rapidly gaining traction, especially for biologics and insulin delivery.
By Technology:
Bluetooth: Most commonly used for device connectivity.
Near-Field Communication (NFC): Gaining popularity for secure and short-range communication.
Others: Wi-Fi and mobile network integration.
By Application:
Asthma and Chronic Obstructive Pulmonary Disease (COPD): The largest application segment.
Diabetes Management: Growing adoption of connected insulin pens and pumps.
Others: Oncology, autoimmune diseases, and cardiovascular conditions.
By Geography:
North America: Leading the market due to advanced healthcare infrastructure and technology adoption.
Europe: Significant growth driven by government initiatives for digital health.
Asia-Pacific: High potential due to increasing healthcare expenditure and rising chronic disease burden.
Rest of the World: Gradual adoption with untapped opportunities.
Get a Customized Report Tailored to Your Requirements:- https://www.mordorintelligence.com/market-analysis/drug-filled-devices
Key Players: Innovators Driving Market Growth
Several key players are shaping the connected drug delivery devices market with continuous innovation, strategic partnerships, and a focus on expanding their product portfolios. Some of the prominent companies include:
Adherium Limited: A pioneer in connected inhalers, providing solutions that improve respiratory medication adherence.
Propeller Health: Offers smart inhalers integrated with mobile apps for data tracking and patient engagement.
Becton, Dickinson and Company: Focuses on connected insulin delivery systems and drug delivery pens.
Phillips-Medisize: Renowned for its expertise in developing wearable drug delivery devices.
Teva Pharmaceuticals: Leading the connected inhaler segment with its ProAir Digihaler.
These companies are investing heavily in R&D and forming collaborations with healthcare providers to enhance device functionality and expand their reach.
Conclusion: A Transformative Future for Drug Delivery
The connected drug delivery devices market is at the forefront of transforming medication management and patient care. With advancements in digital health technologies, increasing prevalence of chronic diseases, and a growing focus on personalized healthcare, the market is set to witness significant growth in the coming years.
Governments, healthcare providers, and manufacturers must collaborate to overcome challenges such as data privacy concerns and high costs. By addressing these barriers, the industry can unlock the full potential of connected drug delivery devices, paving the way for a smarter, more efficient healthcare ecosystem.
Industry Related Reports
Injectables Drug Delivery Devices Type Market: The report provides insights into the Global Injectable Drug Delivery Devices Market, highlighting market share and trends. It segments the market by device type, including Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices, by therapeutic application, encompassing Cardiovascular Diseases, Oncology, Diabetes, Autoimmune Disorders, Hepatitis, and other therapeutic applications, and by geography, covering North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/injectables-drug-delivery-devices-type-market
Implantable Drug Delivery Devices Market: The report explores trends in the Drug Infusion System Market, segmenting it by product type, including Drug Infusion Pumps, Intraocular Drug Delivery Devices, Contraceptive Drug Delivery Devices, Stents, and other products. It also categorizes the market by technology into Biodegradable Implants and Non-biodegradable Implants, and by application, covering Oncology, Cardiovascular, Autoimmune Diseases, Obstetrics and Gynecology, and other applications. Additionally, the report analyzes the market geographically across North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/implantable-drug-delivery-devices-market
UK Drug Delivery Devices Market: The United Kingdom Drug Delivery Devices Market is categorized by Route of Administration, including Injectable, Topical, and Other Routes of Administration. It is further segmented by Application, encompassing Cancer, Cardiovascular, Diabetes, Infectious Diseases, and Other Applications. Additionally, the market is divided by End-User, covering Hospitals, Ambulatory Surgical Centers, and Other End Users.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/uk-drug-delivery-devices-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Connected Drug Delivery Devices Market: Transforming Healthcare with Technology-Driven Innovations here
News-ID: 3786298 • Views: …
More Releases from Mordor Intelligence
Residential EV Charger Market to Reach Approximately USD 32.12 Billion by 2030 w …
Introduction
The residential EV charger market is witnessing a significant surge as homeowners increasingly adopt electric vehicles and seek dedicated charging solutions at home. According to a recent report from Mordor Intelligence, The residential EV charging market is valued at USD 9.68 billion in 2025 and is forecast to climb to roughly USD 32.12 billion by 2030, advancing at a 27.11% CAGR during the period.
This growth reflects more…
South Africa Renewable Energy Market CAGR value to be at 6.00%, Driven by Solar …
South Africa Renewable Energy Market:
South Africa is undergoing a steady shift in its energy landscape, with renewable sources gaining traction across the country. This growth reflects a broader regional trend toward cleaner energy solutions, especially in response to grid instability and rising electricity costs.
The country's energy mix has traditionally been dominated by coal, but recent years have seen a gradual diversification. Solar and wind energy are leading the way, supported…
Artificial Intelligence As A Service Market to Reach USD 98.82 Billion by 2030, …
Mordor Intelligence has published a new report on the Artificial Intelligence as a Service Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Artificial Intelligence as a Service Market Overview
The Artificial Intelligence as a Service Market size is estimated at USD 20.64 billion in 2025, and is expected to reach USD 98.82 billion by 2030, at a CAGR of 36.78% during the forecast period (2025-2030). …
Life Sciences Consulting Market to Reach USD 54.51 Billion by 2030, Driven by Gr …
Mordor Intelligence has published a new report on the Life Sciences Consulting Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Life Sciences Consulting Market Overview
The Life Sciences Consulting Market size is estimated at USD 34.75 billion in 2025, and is expected to reach USD 54.51 billion by 2030, at a CAGR of 9.42% during the forecast period (2025-2030).
The Life Sciences Consulting Market share…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
